Zhang Junyan, Zhu Zhi, Sun Zhe, Sun Xuren, Wang Zhenning, Xu Huimian
Department of Surgical Oncology, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, P.R. China.
Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, P.R. China.
Mol Med Rep. 2014 Feb;9(2):600-6. doi: 10.3892/mmr.2013.1858. Epub 2013 Dec 11.
The aim of this study was to investigate the correlation between the expression of survivin and vascular endothelial growth factor‑C (VEGF‑C) in gastric cancer and the pathway by which survivin may affect gastric cancer lymphatic metastasis. The study may provide novel targets for treating gastric cancer lymphatic metastasis and distal dissemination. Survivin and VEGF‑C expression in gastric carcinoma and peri‑carcinoma (2 cm away from the carcinoma) tissues, obtained from 195 patients who underwent curative gastrectomy surgery (130 cases presented with lymph node metastasis and 65 cases presented without metastasis), was examined immunohistochemically using a tissue microarray. Plasmids containing survivin and VEGF‑C shRNA were constructed and transfected into SGC‑7901 gastric cancer cells. The expression levels of the two genes were examined using western blot analysis and qPCR, and the results were statistically analyzed. The expression levels of survivin and VEGF‑C were 51.3 and 55.4%, respectively, in gastric carcinoma. Survivin and VEGF‑C were located mainly in the cytoplasm of the tumor cells. The expression levels of survivin and VEGF‑C were significantly higher in patients with lymph node metastasis than in those without metastasis (P=0.008 and 0.001, respectively). Patients with high expression levels of survivin and VEGF‑C showed significantly less favorable survival rates compared with patients with low expression levels of those two genes (P=0.003 and 0.039, respectively). Moreover, patients with co‑expression of the two genes usually had a poorer prognosis (P=0.003). However, multivariate analysis demonstrated that neither of the two genes were an independent prognostic determinant. The levels of VEGF‑C expression may be regulated by survivin expression. Conversely, inhibiting VEGF‑C gene expression by shRNA did not reduce survivin expression at the mRNA or protein levels. Survivin and VEGF‑C were expressed in gastric cancer cells and were significantly associated with lymphatic metastasis. Survivin may be a regulator of VEGF‑C expression in gastric cancer cells, and is essential in invasion and lymphatic metastasis. Moreover, survivin may be able to serve as a chemotherapy target for gastric cancer.
本研究旨在探讨胃癌中生存素与血管内皮生长因子-C(VEGF-C)表达之间的相关性,以及生存素可能影响胃癌淋巴转移的途径。该研究可能为治疗胃癌淋巴转移和远处播散提供新的靶点。采用组织芯片免疫组化法检测195例行根治性胃切除术患者(130例有淋巴结转移,65例无转移)的胃癌组织及癌旁组织(距癌组织2 cm)中生存素和VEGF-C的表达。构建含生存素和VEGF-C shRNA的质粒并转染至SGC-7901胃癌细胞。采用蛋白质印迹分析和qPCR检测这两个基因的表达水平,并对结果进行统计学分析。胃癌组织中生存素和VEGF-C的表达水平分别为51.3%和55.4%。生存素和VEGF-C主要位于肿瘤细胞的细胞质中。有淋巴结转移患者的生存素和VEGF-C表达水平显著高于无转移患者(P分别为0.008和0.001)。生存素和VEGF-C高表达患者的生存率显著低于这两个基因低表达患者(P分别为0.003和0.039)。此外,这两个基因共表达的患者通常预后较差(P=0.003)。然而,多因素分析表明这两个基因均不是独立的预后决定因素。VEGF-C的表达水平可能受生存素表达的调控。相反,用shRNA抑制VEGF-C基因表达并未降低mRNA或蛋白质水平的生存素表达。生存素和VEGF-C在胃癌细胞中表达,且与淋巴转移显著相关。生存素可能是胃癌细胞中VEGF-C表达的调节因子,在侵袭和淋巴转移中起重要作用。此外,生存素可能可作为胃癌的化疗靶点。